Overview

Ubrelvy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an acute treatment for migraine in adults. Ubrelvy is also referred to by its drug name, ubrogepant. Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the receptor that CGRP (a protein that can cause migraine headaches) uses to react with the body.

How do I take it?

Prescribing information states that Ubrelvy is available as tablets taken by mouth as needed. You can take Ubrelvy with or without food.

Side effects

The FDA-approved label for Ubrelvy lists common side effects including sleepiness and nausea. Allergic reactions are also possible.

For more details about this treatment, visit:

Ubrelvy — Abbvie https://www.ubrelvy.com UBRELVY- ubrogepant tablet — DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd9f9458-fd96-4688-be3f-f77b3d1af6ab Ubrogepant (Oral Route) — Mayo Clinic https://www.mayoclinic.org/drugs-supplements/ubrogepant-oral-route/side-effects/drg-20481621?p=1